Cancer models developed with 3D bioprinting technology allow for rapid evaluation of individual drug responses.

The DeGregorio Family Foundation with support from the Torrey Coast Foundation Gastro Esophageal Investigator Network Initiative (GEMINI) has awarded $450,000 to Saar Gill, MD, PhD, of the University ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

When a tumor develops, it creates a structure around itself called the tumor stroma, within which blood and lymphatic vessels ...

Characterizing the tumor immune microenvironment enables the identification of new prognostic and predictive biomarkers, the development of novel therapeutic targets and strategies, and the ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

AbbVie and Xilio partner to develop tumor-activated immunotherapies. Xilio's pipeline includes masked T cell engagers for ...

Senescent cells, or ‘zombie’ cells, are damaged cancer cells that remain active, making it harder to treat tumors.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...